Dare Bioscience Inc (DARE)
0.6096
+0.17
(+40.20%)
USD |
NASDAQ |
May 20, 16:00
0.6096
0.00 (0.00%)
After-Hours: 20:00
Dare Bioscience Profit Margin (Quarterly): -72.62K% for March 31, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -72.62K% |
December 31, 2023 | -279.8% |
September 30, 2023 | -829.9% |
June 30, 2023 | |
March 31, 2023 | |
December 31, 2022 | |
September 30, 2022 | |
June 30, 2022 | 4.14% |
March 31, 2022 | |
December 31, 2021 | |
September 30, 2021 | |
June 30, 2021 | |
March 31, 2021 | |
December 31, 2020 | |
September 30, 2020 | |
June 30, 2020 | |
March 31, 2020 | |
December 31, 2019 | |
September 30, 2019 | |
June 30, 2019 | |
March 31, 2019 |
Date | Value |
---|---|
December 31, 2018 | |
September 30, 2018 | |
June 30, 2018 | |
March 31, 2018 | |
December 31, 2017 | |
September 30, 2017 | |
June 30, 2017 | -644.1% |
March 31, 2017 | -531.8% |
December 31, 2016 | -645.6% |
September 30, 2016 | |
June 30, 2016 | |
March 31, 2016 | |
December 31, 2015 | |
September 30, 2015 | |
June 30, 2015 | |
March 31, 2015 | |
December 31, 2014 | |
September 30, 2014 | |
June 30, 2014 | -22.43K% |
March 31, 2014 | -6.20K% |
December 31, 2013 | -58.00K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-72.62K%
Minimum
Mar 2024
4.14%
Maximum
Jun 2022
-18.43K%
Average
-554.8%
Median
Profit Margin (Quarterly) Benchmarks
Altimmune Inc | -487.9K% |
Verastem Inc | -- |
Oragenics Inc | -- |
Actinium Pharmaceuticals Inc | -- |
Orgenesis Inc | -4.01K% |
Profit Margin (Quarterly) Related Metrics
Return on Assets | -127.8% |
Operating Margin (Quarterly) | -64.74K% |
Return on Net Operating Assets | -336.9% |